Scarica l'app Stockscreener
2.21
1.34%
-0.03
Precedente Chiudi:
$2.24
Aprire:
$2.24
Volume 24 ore:
4.36M
Relative Volume:
1.76
Capitalizzazione di mercato:
$748.48M
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-6.3143
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
+16.93%
1M Prestazione:
-3.49%
6M Prestazione:
-27.54%
1 anno Prestazione:
-8.30%
Intervallo 1D:
$2.095
$2.295
Intervallo di 1 settimana:
$1.76
$2.42
Portata 52W:
$1.67
$4.1598
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.21 | 748.48M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
Jones Trading Begins Coverage on Nuvation Bio (NYSE:NUVB) - Defense World
Q1 EPS Estimates for Nuvation Bio Decreased by HC Wainwright - Defense World
Jones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership - TipRanks
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating - Investing.com Australia
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating By Investing.com - Investing.com South Africa
Nuvation Bio initiated with a Buy at JonesResearch - TipRanks
Nuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst Downgrade - Defense World
Nuvation Bio (NYSE:NUVB) Price Target Cut to $10.00 by Analysts at HC Wainwright - Defense World
Nuvation Bio stock price target cut to $10 by H.C. Wainwright - Investing.com Canada
Nuvation Bio (NYSE:NUVB) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Nuvation Bio Inc (NUVB) expanding its growth trajectory ahead - SETE News
Q1 Earnings Estimate for Nuvation Bio Issued By Wedbush - Defense World
Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts - Insider Monkey
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact L - GuruFocus.com
Nuvation Bio Reports Transformative Year in 2024 - TipRanks
12 Best NYSE Penny Stocks to Buy According to Analysts - Insider Monkey
Wedbush Comments on Nuvation Bio’s Q3 Earnings (NYSE:NUVB) - Defense World
Nuvation Bio Positioned for Growth: Buy Rating Affirmed on Strategic Moves and Promising Drug Pipeline - TipRanks
Nuvation Bio Inc Files For Mixed Shelf, Size Not Disclosed -March 06, 2025 at 05:35 pm EST - Marketscreener.com
Nuvation Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Nuvation Bio reports Q4 EPS (15c), two estimates (12c) - TipRanks
Nuvation Bio Inc. SEC 10-K Report - TradingView
Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - WICZ
Nuvation Bio Inc (NYSE: NUVB) Stock Is A Good Option To Consider - Stocks Register
Nuvation Bio Enters Supply Agreement With Asymchem Laboratories -March 05, 2025 at 05:14 pm EST - Marketscreener.com
Nuvation Bio scoops US$250M financing to launch promising lung cancer therapeutic - Mugglehead
Nuvation Bio secures $250m for taletrectinib commercialisation - Yahoo Finance
Nuvation Bio (NYSE:NUVB) Given Outperform Rating at Wedbush - Defense World
Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners - BioSpace
Nuvation Bio secures up to $250M from Sagard Healthcare Partners; shares rise - MSN
New York's Nuvation Bio Nets $250M to Launch Lung Cancer Game-Changer - Hoodline
Nuvation Bio: Up To $250 Million In Non-Dilutive Financings Secured - Pulse 2.0
Midtown biotech raises $250M to bring lung cancer therapy to market - Crain's New York Business
Nuvation Bio to Receive Up to $250 Million in Funding From Sagard Healthcare Partners - Marketscreener.com
RBC bullish on Nuvation as royalty deal, non-dilutive financings remove overhang - TipRanks
Nuvation Bio nabs $250 million to launch cancer drug - The Pharma Letter
Nuvation Bio Secures Up To $250 Million In Non-Dilutive Financings From Sagard Healthcare Partners - Marketscreener.com
Nuvation Bio secures $250 million for cancer drug launch - Investing.com
Nuvation Bio (NUVB) to Release Quarterly Earnings on Thursday - MarketBeat
Nuvation Bio (NUVB) to Release Earnings on Thursday - Defense World
Analyzing Sage Therapeutics (NASDAQ:SAGE) and Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio to Present at the TD Cowen 45th Annual Health Care Conference - BioSpace
Nuvation Bio Inc. (NYSE:NUVB) Short Interest Up 14.3% in January - MarketBeat
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm - The Eastern Progress Online
What Do Wall Street Analysts Think About Nuvation Bio Inc (NYSE: NUVB) Stock? - Stocks Register
Peapod Lane Capital LLC Makes New $1.04 Million Investment in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio executive departs after key milestones By Investing.com - Investing.com Nigeria
Nuvation Bio executive departs after key milestones - MSN
Nuvation BioPending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst (NUVB) - Seeking Alpha
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):